Modified CAR-T Therapy Shows Potential for Treating Myasthenia Gravis, a Nervous System Autoimmune Disorders
Former FDA Second-in-Command & COO and Harvard Faculty Member Dr. John Norris Speaks: It is A Race Against Time: Again, We Are Not Prepared for the Coming Catastrophe